               SEQUENCE LISTING

<110> Covagen AG

<120> Novel bispecific binding molecules with antitumoral activity

<130> W1579 PCT

<150> EP 13 16 4555.8
<151> 2013-04-19

<160> 209

<170> BiSSAP 1.2

<210> 1
<211> 63
<212> PRT
<213> Homo sapiens


<400> 1
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Thr Glu 
1               5                   10                  15      
Asp Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Asn Ser 
            20                  25                  30          
Ser Glu Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 2
<211> 449
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-CD3 antibody

<400> 2
Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      
Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Tyr 
            20                  25                  30          
Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              
Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn Gln Lys Val 
    50                  55                  60                  
Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Ala Phe 
65                  70                  75                  80  
Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val Tyr Phe Cys 
                85                  90                  95      
Ala Arg Tyr Tyr Asp Asp His Tyr Cys Leu Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         
Thr Pro Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe 
        115                 120                 125             
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu 
    130                 135                 140                 
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp 
145                 150                 155                 160 
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu 
                165                 170                 175     
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser 
            180                 185                 190         
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro 
        195                 200                 205             
Ser Asn Thr Lys Val Asp Lys Lys Val Glu Pro Lys Ser Cys Asp Lys 
    210                 215                 220                 
Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Ala Ala Gly Gly Pro 
225                 230                 235                 240 
Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser 
                245                 250                 255     
Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp 
            260                 265                 270         
Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn 
        275                 280                 285             
Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val 
    290                 295                 300                 
Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu 
305                 310                 315                 320 
Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys 
                325                 330                 335     
Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr 
            340                 345                 350         
Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr 
        355                 360                 365             
Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu 
    370                 375                 380                 
Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu 
385                 390                 395                 400 
Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys 
                405                 410                 415     
Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu 
            420                 425                 430         
Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly 
        435                 440                 445             
Lys 
    

<210> 3
<211> 213
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-CD3 antibody

<400> 3
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      
Asp Arg Val Thr Ile Thr Cys Ser Ala Ser Ser Ser Val Ser Tyr Met 
            20                  25                  30          
Asn Trp Tyr Gln Gln Thr Pro Gly Lys Ala Pro Lys Arg Trp Ile Tyr 
        35                  40                  45              
Asp Thr Ser Lys Leu Ala Ser Gly Val Pro Ser Arg Phe Ser Gly Ser 
    50                  55                  60                  
Gly Ser Gly Thr Asp Tyr Thr Phe Thr Ile Ser Ser Leu Gln Pro Glu 
65                  70                  75                  80  
Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Trp Ser Ser Asn Pro Phe Thr 
                85                  90                  95      
Phe Gly Gln Gly Thr Lys Leu Gln Ile Thr Arg Thr Val Ala Ala Pro 
            100                 105                 110         
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr 
        115                 120                 125             
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys 
    130                 135                 140                 
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu 
145                 150                 155                 160 
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser 
                165                 170                 175     
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala 
            180                 185                 190         
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe 
        195                 200                 205             
Asn Arg Gly Glu Cys 
    210             

<210> 4
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer C12

<400> 4
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Arg Met 
            20                  25                  30          
Glu Asp Gly Val Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 5
<211> 68
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<220> 
<221> VARIANT
<222> 12,13,14,15,16,17,18,34,35,36,41,44,53,55,59
<223> Gly, Val, Thr, Leu, Phe, Ala, Tyr, Asp, Ser, His, Lys, Glu, Gln,
      Ile, Trp, Arg, Met, Pro, Asn, Cys

<220> 
<221> VARIANT
<222> 19,20,21,37,38,39
<223> Gly, Val, Thr, Leu, Phe, Ala, Tyr, Asp, Ser, His, Lys, Glu, Gln,
      Ile, Trp, Arg, Met, Pro, Asn, Cys

<400> 5
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      
Xaa Xaa Xaa Xaa Xaa Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu Xaa Xaa Xaa Xaa Xaa Xaa Gly Xaa Trp Trp Xaa Ala Arg Ser Leu 
        35                  40                  45              
Thr Thr Gly Glu Xaa Gly Xaa Ile Pro Ser Xaa Tyr Val Ala Pro Val 
    50                  55                  60                  
Asp Ser Ile Gln 
65              

<210> 6
<211> 68
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<220> 
<221> VARIANT
<222> 12
<223> Thr, Glu, Asp, Gln, Tyr, Val, Trp, Asn, Ser, Phe, Lys

<220> 
<221> VARIANT
<222> 13
<223> Ser, Ala, Arg, Thr

<220> 
<221> VARIANT
<222> 14
<223> Tyr, Arg, His, Thr, Asn, Val, Trp, Ser

<220> 
<221> VARIANT
<222> 15
<223> Asn, Asp, Met, Tyr, Arg, Pro, Glu, Leu, His, Thr, Gly, Phe

<220> 
<221> VARIANT
<222> 16
<223> Thr, Ser, Pro, Gln, Arg, Lys, Gly, Ala, Asp, Met, Asn, Leu, Phe,
      Tyr, Glu

<220> 
<221> VARIANT
<222> 17
<223> Arg, Met, Lys, Asp, Phe, Thr, Gly, His, Ser, Pro, Asn, Gln, Tyr,
      Leu, Ala, Pro

<220> 
<221> VARIANT
<222> 19
<223> Asp, Gly, Val, Leu, His, Asn, Arg, Phe, Ser, Ala

<220> 
<221> VARIANT
<222> 19
<223> Gly, Ser, Glu, Asp, Pro, Tyr or is absent

<220> 
<221> VARIANT
<222> 20
<223> Gln, Asp, Ser, His or is absent

<220> 
<221> VARIANT
<222> 21
<223> Asp, Val or is absent

<220> 
<221> VARIANT
<222> 34
<223> Arg, Lys, Gln, Asn, Ser, Gly, Trp, Met, His, Leu, Phe, Glu, Thr,
      Pro, Ala, Asp, Val

<220> 
<221> VARIANT
<222> 35
<223> Met, Arg, Glu, Gly, Asn, Asp, Ser, Ala, Gln, Phe, Pro, Lys, Tyr,
      Thr, His, Val, Leu, Trp

<220> 
<221> VARIANT
<222> 36
<223> Glu, Trp, Pro, Arg, Lys, Ser, Val, Asn, Asp, His, Gly, Thr, Gln,
      Ala, Tyr, Leu, Met

<220> 
<221> VARIANT
<222> 37
<223> Asp, Arg, Gln, Ser, Ala, Asn, Pro, Ile, His, Thr, Tyr, Glu, Leu,
      Lys, Met, Val, Ile, Trp or is absent

<220> 
<221> VARIANT
<222> 38
<223> Gly, Ser, Ile, Leu, Ala, Val, Thr, Glu, Asp, Gln, Arg, Pro, Lys,
      Met, His, Tyr or is absent

<220> 
<221> VARIANT
<222> 39
<223> Lys, Gly, Arg, Ala, Thr, Val, Ser, Ile, Glu, Gln, Pro, Asp, Asn,
      His or is absent

<220> 
<221> VARIANT
<222> 41
<223> Val, Asp, Thr, Ile, Tyr

<220> 
<221> VARIANT
<222> 44
<223> Glu, Ala, Arg, Thr, Gln

<220> 
<221> VARIANT
<222> 53
<223> Thr, Ile, Val

<220> 
<221> VARIANT
<222> 55
<223> Tyr, Leu, Phe

<220> 
<221> VARIANT
<222> 59
<223> Asn, Ser

<400> 6
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      
Xaa Xaa Xaa Xaa Xaa Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu Xaa Xaa Xaa Xaa Xaa Xaa Gly Xaa Trp Trp Xaa Ala Arg Ser Leu 
        35                  40                  45              
Thr Thr Gly Glu Xaa Gly Xaa Ile Pro Ser Xaa Tyr Val Ala Pro Val 
    50                  55                  60                  
Asp Ser Ile Gln 
65              

<210> 7
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> mutated RT-loop

<400> 7
Thr Ser Tyr Asn Thr Arg Asp 
1               5           

<210> 8
<211> 4
<212> PRT
<213> Artificial Sequence

<220> 
<223> mutated SRC-loop

<400> 8
Arg Met Glu Asp 
1               

<210> 9
<211> 67
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 9
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Asp Ser 
1               5                   10                  15      
Met Gly Gly Gln Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu Lys Arg Trp Arg Gly Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr 
        35                  40                  45              
Thr Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp 
    50                  55                  60                  
Ser Ile Gln 
65          

<210> 10
<211> 67
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 10
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Asp Ser 
1               5                   10                  15      
Met Gly Gly Gln Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu Thr Arg Trp Ala Gln Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr 
        35                  40                  45              
Thr Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp 
    50                  55                  60                  
Ser Ile Gln 
65          

<210> 11
<211> 64
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 11
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Gln Ala Tyr Gly Met 
1               5                   10                  15      
Tyr Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ser Pro 
            20                  25                  30          
Lys Asp Thr Gly Tyr Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu 
        35                  40                  45              
Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60                  



<210> 12
<211> 66
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 12
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Glu Phe 
1               5                   10                  15      
Met Gly Gly Gln Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu Thr Met Trp Lys Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr 
        35                  40                  45              
Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser 
    50                  55                  60                  
Ile Gln 
65      

<210> 13
<211> 67
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 13
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Pro Tyr 
1               5                   10                  15      
Leu Gly Gly Gln Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu His Ala Ser Met Leu Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr 
        35                  40                  45              
Thr Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp 
    50                  55                  60                  
Ser Ile Gln 
65          

<210> 14
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 14
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Gln 
1               5                   10                  15      
His Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gly Asp 
            20                  25                  30          
Asn Ile Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 15
<211> 67
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 15
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Leu Ser 
1               5                   10                  15      
Ser His Pro His Val Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu Asn Arg Val Ser Ile Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr 
        35                  40                  45              
Thr Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp 
    50                  55                  60                  
Ser Ile Gln 
65          

<210> 16
<211> 67
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 16
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Pro Tyr 
1               5                   10                  15      
Leu Gly Gly Gln Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu Asn His Pro Pro Thr Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr 
        35                  40                  45              
Thr Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp 
    50                  55                  60                  
Ser Ile Gln 
65          

<210> 17
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 17
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Tyr Asp Leu 
1               5                   10                  15      
Ser Arg Pro Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu 
            20                  25                  30          
Asn Ser Ser Glu Gly Thr Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Phe Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 18
<211> 67
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 18
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Met Pro 
1               5                   10                  15      
Lys Val Ser Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu 
            20                  25                  30          
Gln Glu Pro Gln Ser Lys Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr 
        35                  40                  45              
Thr Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp 
    50                  55                  60                  
Ser Ile Gln 
65          

<210> 19
<211> 67
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 19
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Pro Gly 
1               5                   10                  15      
Arg His Ser Ser Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu His Gln Ser Asn Val Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr 
        35                  40                  45              
Thr Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp 
    50                  55                  60                  
Ser Ile Gln 
65          

<210> 20
<211> 64
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 20
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Gln Thr Thr Arg Pro 
1               5                   10                  15      
His Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gly Arg 
            20                  25                  30          
Thr Gln Ile Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu 
        35                  40                  45              
Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60                  



<210> 21
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 21
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Gln Thr Asn Asn Ser 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gly Asn 
            20                  25                  30          
Thr Gln Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 22
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 22
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Tyr Ser Tyr Asn Thr 
1               5                   10                  15      
His Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ser Arg 
            20                  25                  30          
Ala Asn Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 23
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 23
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Tyr Ser Tyr Asn Asn 
1               5                   10                  15      
His Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gln Glu 
            20                  25                  30          
Leu Gln Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 24
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 24
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Arg Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Thr Lys 
            20                  25                  30          
Ser Ser Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 25
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 25
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Lys Ala 
            20                  25                  30          
His Ser Leu Ala Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 26
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 26
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ser Glu 
            20                  25                  30          
Gln Asp Leu Arg Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 27
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 27
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Lys 
1               5                   10                  15      
Leu Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Arg Thr 
            20                  25                  30          
Asp Ala Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 28
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 28
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Gln 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gly Pro 
            20                  25                  30          
Lys Leu Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 29
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 29
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Asn 
1               5                   10                  15      
His Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Asn Gln 
            20                  25                  30          
His Asn Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 30
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 30
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Leu 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Asn Ser 
            20                  25                  30          
Ser Glu Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 31
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 31
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Pro 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gly Ala 
            20                  25                  30          
Thr Asp Ala Thr Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 32
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 32
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Asn Glu 
            20                  25                  30          
Leu Asn Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 33
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 33
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Ser 
1               5                   10                  15      
Ser Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Arg Glu 
            20                  25                  30          
Ala Asp Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 34
<211> 67
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 34
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Arg Asp 
1               5                   10                  15      
His Ser Pro His Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu Asn Leu Tyr Gln Val Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr 
        35                  40                  45              
Thr Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp 
    50                  55                  60                  
Ser Ile Gln 
65          

<210> 35
<211> 66
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 35
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Glu Ala 
1               5                   10                  15      
Leu Gly Gly Gln Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu Ser Pro Gln Thr Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr 
        35                  40                  45              
Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser 
    50                  55                  60                  
Ile Gln 
65      

<210> 36
<211> 64
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 36
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Tyr Ser Val His Pro 
1               5                   10                  15      
Gly Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ser Asn 
            20                  25                  30          
Tyr Gln Val Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu 
        35                  40                  45              
Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60                  



<210> 37
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 37
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Tyr Ser Tyr Asn Ser 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ala Gln 
            20                  25                  30          
His Asp Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 38
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 38
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Met 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gly Arg 
            20                  25                  30          
Gly Pro Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 39
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 39
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gly Arg 
            20                  25                  30          
Pro Arg Asp Val Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 40
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 40
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu His Thr 
            20                  25                  30          
Thr Lys Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 41
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 41
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Thr Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu His Trp 
            20                  25                  30          
Asn Gly Gly Ser Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 42
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 42
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Thr Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Asn Asn 
            20                  25                  30          
Thr Thr Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 43
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 43
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Trp Ser Tyr Asn Ser 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Asn Pro 
            20                  25                  30          
Glu Glu Thr Ser Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 44
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 44
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Pro 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Asn Pro 
            20                  25                  30          
Arg Gln Arg Ile Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 45
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 45
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Asn Arg 
            20                  25                  30          
Pro Met Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 46
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 46
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Gln 
1               5                   10                  15      
His Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Pro Thr 
            20                  25                  30          
Thr Asp Thr Ala Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 47
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 47
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Met Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Arg Glu 
            20                  25                  30          
Thr Thr Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 48
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 48
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
His Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Arg Gln 
            20                  25                  30          
Asn Asn Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 49
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 49
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Ser 
1               5                   10                  15      
Thr Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ser Ala 
            20                  25                  30          
Pro Gln Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 50
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 50
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Ala 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ser Ala 
            20                  25                  30          
Pro Thr Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 51
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 51
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ser Asp 
            20                  25                  30          
Ala Thr Leu Glu Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 52
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 52
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Lys 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ser Glu 
            20                  25                  30          
Thr Ser Pro Glu Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 53
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 53
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Val Ser Tyr Asn Thr 
1               5                   10                  15      
Thr Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ser His 
            20                  25                  30          
Thr Thr Ser Gln Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 54
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 54
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Thr Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ser Met 
            20                  25                  30          
Ala Val Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 55
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 55
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ser Asn 
            20                  25                  30          
Gly Pro Asp Pro Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 56
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 56
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Thr Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ser Asn 
            20                  25                  30          
Pro Pro Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 57
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 57
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Asn Ser Tyr Asn Lys 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ser Gln 
            20                  25                  30          
Ala Ala Glu Asp Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 58
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 58
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Lys Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ser Gln 
            20                  25                  30          
Ser Gly Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 59
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 59
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ser Tyr 
            20                  25                  30          
Pro Arg Thr Gln Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 60
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 60
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Glu 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Thr Lys 
            20                  25                  30          
Thr Pro Arg Gln Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 61
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 61
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Val Ser Tyr Asn Thr 
1               5                   10                  15      
Asn Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Asp Ser 
            20                  25                  30          
Gln Glu Pro Asn Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 62
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 62
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Gln 
1               5                   10                  15      
His Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gly Gln 
            20                  25                  30          
Tyr Pro Lys Thr Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 63
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 63
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Asn 
1               5                   10                  15      
Thr Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Lys Gln 
            20                  25                  30          
Gln Ala Gly Asp Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 64
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 64
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Asn 
1               5                   10                  15      
Thr Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Asn Ala 
            20                  25                  30          
His Gln Ser Ala Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 65
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 65
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Asn Pro 
            20                  25                  30          
Gln Ser Arg Thr Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 66
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 66
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Ser 
1               5                   10                  15      
His Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Pro Gly 
            20                  25                  30          
Gln Ser Met Thr Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 67
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 67
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Ala 
1               5                   10                  15      
His Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Pro Arg 
            20                  25                  30          
Gln Asp Thr Ala Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 68
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 68
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gln Ala 
            20                  25                  30          
Leu Gly Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 69
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 69
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Glu 
1               5                   10                  15      
Phe Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gln Gly 
            20                  25                  30          
Thr Gln Leu Ala Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 70
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 70
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Asp 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gln His 
            20                  25                  30          
Lys Glu Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 71
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 71
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Tyr Ser Tyr Asn Asn 
1               5                   10                  15      
Thr Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gln Lys 
            20                  25                  30          
Arg Gln Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 72
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 72
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Ser 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gln Lys 
            20                  25                  30          
Ser Gln Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 73
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 73
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gln Pro 
            20                  25                  30          
Asn Ser Ala Gln Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 74
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 74
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gln Pro 
            20                  25                  30          
Gln Val Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 75
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 75
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Tyr Ser Tyr Asn Lys 
1               5                   10                  15      
Thr Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gln Gln 
            20                  25                  30          
His Glu Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 76
<211> 64
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 76
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Leu 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gln Gln 
            20                  25                  30          
Asn Leu Asp Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu 
        35                  40                  45              
Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60                  



<210> 77
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 77
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Leu 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gln Ser 
            20                  25                  30          
His Gln Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 78
<211> 64
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 78
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Ser 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gln Ser 
            20                  25                  30          
Arg Ala Ser Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu 
        35                  40                  45              
Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60                  



<210> 79
<211> 64
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 79
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Ala 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gln Thr 
            20                  25                  30          
Ser Leu Thr Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu 
        35                  40                  45              
Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60                  



<210> 80
<211> 64
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 80
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Ser 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gln Thr 
            20                  25                  30          
Thr Ala Met Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu 
        35                  40                  45              
Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60                  



<210> 81
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 81
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Arg 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gln Val 
            20                  25                  30          
Asn Pro Met Asp Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 82
<211> 64
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 82
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Arg Gln 
            20                  25                  30          
Gln Arg Gly Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu 
        35                  40                  45              
Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60                  



<210> 83
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 83
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Arg Val 
            20                  25                  30          
Pro Gln Asp Asp Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 84
<211> 64
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 84
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Pro 
1               5                   10                  15      
Asn Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ser Gln 
            20                  25                  30          
Gln Asp Gly Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu 
        35                  40                  45              
Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60                  



<210> 85
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 85
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Arg 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ser Ser 
            20                  25                  30          
Asn Arg Ala Gln Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 86
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 86
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Asn 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Thr Pro 
            20                  25                  30          
Asp Ser Arg Gln Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 87
<211> 64
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 87
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Ser 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Thr Pro 
            20                  25                  30          
Pro Gln His Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu 
        35                  40                  45              
Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60                  



<210> 88
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 88
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Asn 
1               5                   10                  15      
Thr Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Thr Gln 
            20                  25                  30          
Asp Pro Leu His Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 89
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 89
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Asp 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Thr Gln 
            20                  25                  30          
Lys Gln Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 90
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 90
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Ser Ser Tyr Asn Thr 
1               5                   10                  15      
Thr Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Thr Gln 
            20                  25                  30          
Pro Pro Leu Ser Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 91
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 91
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Gln Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Asp Ser 
            20                  25                  30          
Glu Thr Gly Lys Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 92
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 92
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Gln 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Arg Lys 
            20                  25                  30          
Pro Lys Tyr Asn Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 93
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 93
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Gln 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ser Glu 
            20                  25                  30          
Pro Leu Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 94
<211> 64
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 94
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Gln 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Val His 
            20                  25                  30          
Asp Pro Ala Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu 
        35                  40                  45              
Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60                  



<210> 95
<211> 62
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 95
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Val Ser Trp Asn Thr 
1               5                   10                  15      
Leu Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Arg Met 
            20                  25                  30          
Pro Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr Gly 
        35                  40                  45              
Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60          

<210> 96
<211> 64
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 96
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Leu Tyr 
1               5                   10                  15      
Ser Leu Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Asn 
            20                  25                  30          
Arg Arg Trp Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu 
        35                  40                  45              
Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60                  



<210> 97
<211> 64
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 97
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Ser 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ala Pro 
            20                  25                  30          
Pro Asn Gly Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu 
        35                  40                  45              
Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60                  



<210> 98
<211> 64
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 98
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Ser 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ala Arg 
            20                  25                  30          
Met Pro Pro Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu 
        35                  40                  45              
Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60                  



<210> 99
<211> 66
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 99
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Phe Arg 
1               5                   10                  15      
Arg Asn Tyr Ser Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu Ser Ala Gln Gln Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr 
        35                  40                  45              
Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser 
    50                  55                  60                  
Ile Gln 
65      

<210> 100
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 100
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Asp Arg Arg Tyr Gly 
1               5                   10                  15      
Ala Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Arg Asp 
            20                  25                  30          
Glu Ala Val Ser Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 101
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 101
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu His Asp 
            20                  25                  30          
Pro Pro Ser Asn Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 102
<211> 64
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 102
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Tyr Ala 
1               5                   10                  15      
Pro Ala Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Asn 
            20                  25                  30          
His Asp Arg Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu 
        35                  40                  45              
Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60                  



<210> 103
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 103
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Ser Tyr Pro 
1               5                   10                  15      
Gly Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ser Asn 
            20                  25                  30          
Asp Pro Val His Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 104
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 104
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Gln Thr Trp Thr Pro 
1               5                   10                  15      
Gly Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Thr Gln 
            20                  25                  30          
Asp Glu Gln Gln Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 105
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 105
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Phe Thr Asn Thr Pro 
1               5                   10                  15      
Gly Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Asn Thr 
            20                  25                  30          
Ser Tyr Leu Thr Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 106
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 106
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Lys Thr His Asn Pro 
1               5                   10                  15      
Gly Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gln Gly 
            20                  25                  30          
Arg Val Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 107
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 107
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Gln Thr Tyr Thr Pro 
1               5                   10                  15      
Gly Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ser Lys 
            20                  25                  30          
Pro Pro Gln Thr Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 108
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 108
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Tyr Gln 
1               5                   10                  15      
Asp Leu Glu Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu 
            20                  25                  30          
Asn Gly Arg Arg Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 109
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 109
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Asp Arg His Tyr Thr 
1               5                   10                  15      
Phe Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gln Asn 
            20                  25                  30          
Lys Gln Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 110
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 110
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ser Asp 
            20                  25                  30          
Ser Asp Gly Val Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 111
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 111
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Asp Arg 
1               5                   10                  15      
Pro Thr Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gly 
            20                  25                  30          
Asp Glu Gln Ile Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 112
<211> 64
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 112
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Thr Tyr Arg Lys 
1               5                   10                  15      
Gly Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Asn Arg 
            20                  25                  30          
Val Ser Ile Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu 
        35                  40                  45              
Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60                  



<210> 113
<211> 64
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 113
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Asn Arg 
            20                  25                  30          
Val Ser Ile Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu 
        35                  40                  45              
Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60                  



<210> 114
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 114
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gly Asp 
            20                  25                  30          
Asn Ile Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 115
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 115
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Asn Ser 
            20                  25                  30          
Ser Asp Gly Thr Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 116
<211> 64
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 116
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Trp Ser 
            20                  25                  30          
Asp Ala Leu Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu 
        35                  40                  45              
Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60                  



<210> 117
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 117
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Met Ala 
            20                  25                  30          
Trp Ala Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 118
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 118
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Glu Gly 
1               5                   10                  15      
Gly Asn Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Asn 
            20                  25                  30          
Arg Val Ser Ile Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 119
<211> 66
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 119
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala His Asp Gln 
1               5                   10                  15      
His Arg Pro Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu 
            20                  25                  30          
Asn Arg Val Ser Ile Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr 
        35                  40                  45              
Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser 
    50                  55                  60                  
Ile Gln 
65      

<210> 120
<211> 66
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 120
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Leu Ser 
1               5                   10                  15      
Ser His Pro His Val Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu Asn Ser Ser Ala Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr 
        35                  40                  45              
Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser 
    50                  55                  60                  
Ile Gln 
65      

<210> 121
<211> 64
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 121
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Ser 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Leu Met 
            20                  25                  30          
His Pro Gly Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu 
        35                  40                  45              
Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60                  



<210> 122
<211> 64
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 122
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg His Ala 
1               5                   10                  15      
Pro Val Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gly 
            20                  25                  30          
Asp Asn Ile Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu 
        35                  40                  45              
Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60                  



<210> 123
<211> 64
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 123
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Thr Lys 
1               5                   10                  15      
His Phe Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ser 
            20                  25                  30          
Gln Pro His Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu 
        35                  40                  45              
Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60                  



<210> 124
<211> 64
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 124
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg His Glu 
1               5                   10                  15      
Asn Phe Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Asn 
            20                  25                  30          
Arg Gly Ala Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu 
        35                  40                  45              
Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60                  



<210> 125
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 125
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Pro Asp 
1               5                   10                  15      
Ser His Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Asn 
            20                  25                  30          
Arg Val Ser Ile Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 126
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 126
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Arg Thr 
1               5                   10                  15      
His Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ser Gln 
            20                  25                  30          
Pro His Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 127
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 127
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Pro Met 
1               5                   10                  15      
Ser Ser Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Asn 
            20                  25                  30          
Arg Val Ser Ile Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 128
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 128
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Arg Phe 
            20                  25                  30          
Asn Pro Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Ser Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 129
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 129
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Phe Pro 
            20                  25                  30          
Asp Asp Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 130
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 130
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ser Gln 
            20                  25                  30          
Pro His Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 131
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 131
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gly Lys 
            20                  25                  30          
Gly Ser Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 132
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 132
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Ser 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ser Asp 
            20                  25                  30          
Gln His Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 133
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 133
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Asp 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ser Ala 
            20                  25                  30          
Pro Gln Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 134
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 134
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Asp 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Glu Tyr 
            20                  25                  30          
Thr Thr Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 135
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 135
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Thr Thr 
            20                  25                  30          
Glu Ala Thr Asp Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 136
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 136
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Ser 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gln Asn 
            20                  25                  30          
Ser Gln Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 137
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 137
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Ser 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gly Asn 
            20                  25                  30          
Thr Gln Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 138
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 138
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Ala 
1               5                   10                  15      
Gln Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gly Ala 
            20                  25                  30          
Arg Tyr Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 139
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 139
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Ala 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gly His 
            20                  25                  30          
His Ser Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 140
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 140
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Met 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Asn Asn 
            20                  25                  30          
Ser Asp Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 141
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 141
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Asp 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ser Lys 
            20                  25                  30          
Asp Ser Ala Leu Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 142
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 142
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Ser 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Asn Arg 
            20                  25                  30          
Gly Ala Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 143
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 143
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
His Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Lys Met 
            20                  25                  30          
Gln Ser Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 144
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 144
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Arg 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Glu Thr 
            20                  25                  30          
Gln Asn Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 145
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 145
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Ala 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gly Ser 
            20                  25                  30          
Thr Ala Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 146
<211> 67
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 146
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Asp Ser 
1               5                   10                  15      
Met Gly Gly Gln Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu Arg Ser Trp Pro Glu Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr 
        35                  40                  45              
Thr Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp 
    50                  55                  60                  
Ser Ile Gln 
65          

<210> 147
<211> 67
<212> PRT
<213> Artificial Sequence

<220> 
<223> ant-HER2 Fynomer

<400> 147
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Asp Ser 
1               5                   10                  15      
Met Gly Gly Gln Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu Lys Thr Trp Glu Gly Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr 
        35                  40                  45              
Thr Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp 
    50                  55                  60                  
Ser Ile Gln 
65          

<210> 148
<211> 67
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 148
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Asp Ser 
1               5                   10                  15      
Met Gly Gly Gln Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu Gln Ala Trp Gln Glu Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr 
        35                  40                  45              
Thr Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp 
    50                  55                  60                  
Ser Ile Gln 
65          

<210> 149
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 149
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Arg Met 
            20                  25                  30          
Glu Asp Gly Val Trp Trp Ala Ala Arg Ser Leu Thr Thr Gly Glu Ile 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 150
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 150
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Arg Met 
            20                  25                  30          
Glu Asp Gly Val Trp Trp Arg Ala Arg Ser Leu Thr Thr Gly Glu Ile 
        35                  40                  45              
Gly Leu Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 151
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 151
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Arg Met 
            20                  25                  30          
Glu Asp Gly Val Trp Trp Thr Ala Arg Ser Leu Thr Thr Gly Glu Val 
        35                  40                  45              
Gly Phe Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 152
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 152
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Arg Met 
            20                  25                  30          
Glu Asp Gly Ile Trp Trp Gln Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Phe Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 153
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 153
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Gln Ala Tyr Gly Met 
1               5                   10                  15      
Tyr Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Pro Pro 
            20                  25                  30          
Tyr Pro Thr Gly Gly Tyr Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 154
<211> 64
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 154
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Gln Ala Tyr Gly Met 
1               5                   10                  15      
Tyr Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Gln Val 
            20                  25                  30          
Leu Asp Asn Gly Tyr Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu 
        35                  40                  45              
Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60                  



<210> 155
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 155
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Gln Ala Tyr Gly Met 
1               5                   10                  15      
Tyr Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Thr Ala 
            20                  25                  30          
Leu Pro Asp Arg Gly Tyr Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 156
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 156
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Arg Asp 
            20                  25                  30          
Asp Asp Gly Val Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 157
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 157
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ser Phe 
            20                  25                  30          
Gln Ser Ala Gly Gly Val Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 158
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 158
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ala Arg 
            20                  25                  30          
Asp Asn Gly Val Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 159
<211> 66
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<400> 159
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Asp Ser 
1               5                   10                  15      
Met Gly Gly Gln Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu Trp Asn Thr Gly Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr 
        35                  40                  45              
Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser 
    50                  55                  60                  
Ile Gln 
65      

<210> 160
<211> 5
<212> PRT
<213> Artificial Sequence

<220> 
<223> GS-linker

<400> 160
Gly Gly Gly Gly Ser 
1               5   

<210> 161
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> GS-linker

<400> 161
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser 
1               5                   10  

<210> 162
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> GS-linker

<400> 162
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser 
1               5                   10                  15  

<210> 163
<211> 527
<212> PRT
<213> Artificial Sequence

<220> 
<223> COVA420 Heavy Chain

<400> 163
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
1               5                   10                  15      
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Arg Met 
            20                  25                  30          
Glu Asp Gly Val Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln Gly 
    50                  55                  60                  
Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Val 
65                  70                  75                  80  
Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln Pro Gly Arg Ser Leu 
                85                  90                  95      
Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Tyr Thr Met 
            100                 105                 110         
His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile Gly Tyr 
        115                 120                 125             
Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn Gln Lys Val Lys Asp 
    130                 135                 140                 
Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Ala Phe Leu Gln 
145                 150                 155                 160 
Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val Tyr Phe Cys Ala Arg 
                165                 170                 175     
Tyr Tyr Asp Asp His Tyr Cys Leu Asp Tyr Trp Gly Gln Gly Thr Pro 
            180                 185                 190         
Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe Pro Leu 
        195                 200                 205             
Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu Gly Cys 
    210                 215                 220                 
Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp Asn Ser 
225                 230                 235                 240 
Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu Gln Ser 
                245                 250                 255     
Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser Ser Ser 
            260                 265                 270         
Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro Ser Asn 
        275                 280                 285             
Thr Lys Val Asp Lys Lys Val Glu Pro Lys Ser Cys Asp Lys Thr His 
    290                 295                 300                 
Thr Cys Pro Pro Cys Pro Ala Pro Glu Ala Ala Gly Gly Pro Ser Val 
305                 310                 315                 320 
Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr 
                325                 330                 335     
Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp Pro Glu 
            340                 345                 350         
Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn Ala Lys 
        355                 360                 365             
Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser 
    370                 375                 380                 
Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys 
385                 390                 395                 400 
Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys Thr Ile 
                405                 410                 415     
Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro 
            420                 425                 430         
Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr Cys Leu 
        435                 440                 445             
Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn 
    450                 455                 460                 
Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser 
465                 470                 475                 480 
Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser Arg 
                485                 490                 495     
Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu 
            500                 505                 510         
His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys 
        515                 520                 525         

<210> 164
<211> 213
<212> PRT
<213> Artificial Sequence

<220> 
<223> COVA420 Light Chain

<400> 164
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      
Asp Arg Val Thr Ile Thr Cys Ser Ala Ser Ser Ser Val Ser Tyr Met 
            20                  25                  30          
Asn Trp Tyr Gln Gln Thr Pro Gly Lys Ala Pro Lys Arg Trp Ile Tyr 
        35                  40                  45              
Asp Thr Ser Lys Leu Ala Ser Gly Val Pro Ser Arg Phe Ser Gly Ser 
    50                  55                  60                  
Gly Ser Gly Thr Asp Tyr Thr Phe Thr Ile Ser Ser Leu Gln Pro Glu 
65                  70                  75                  80  
Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Trp Ser Ser Asn Pro Phe Thr 
                85                  90                  95      
Phe Gly Gln Gly Thr Lys Leu Gln Ile Thr Arg Thr Val Ala Ala Pro 
            100                 105                 110         
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr 
        115                 120                 125             
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys 
    130                 135                 140                 
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu 
145                 150                 155                 160 
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser 
                165                 170                 175     
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala 
            180                 185                 190         
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe 
        195                 200                 205             
Asn Arg Gly Glu Cys 
    210             

<210> 165
<211> 527
<212> PRT
<213> Artificial Sequence

<220> 
<223> COVA422 Heavy Chain

<400> 165
Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      
Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Tyr 
            20                  25                  30          
Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              
Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn Gln Lys Val 
    50                  55                  60                  
Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Ala Phe 
65                  70                  75                  80  
Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val Tyr Phe Cys 
                85                  90                  95      
Ala Arg Tyr Tyr Asp Asp His Tyr Cys Leu Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         
Thr Pro Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe 
        115                 120                 125             
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu 
    130                 135                 140                 
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp 
145                 150                 155                 160 
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu 
                165                 170                 175     
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser 
            180                 185                 190         
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro 
        195                 200                 205             
Ser Asn Thr Lys Val Asp Lys Lys Val Glu Pro Lys Ser Cys Asp Lys 
    210                 215                 220                 
Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Ala Ala Gly Gly Pro 
225                 230                 235                 240 
Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser 
                245                 250                 255     
Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp 
            260                 265                 270         
Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn 
        275                 280                 285             
Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val 
    290                 295                 300                 
Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu 
305                 310                 315                 320 
Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys 
                325                 330                 335     
Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr 
            340                 345                 350         
Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr 
        355                 360                 365             
Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu 
    370                 375                 380                 
Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu 
385                 390                 395                 400 
Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys 
                405                 410                 415     
Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu 
            420                 425                 430         
Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly 
        435                 440                 445             
Lys Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser 
    450                 455                 460                 
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Thr Ser Tyr Asn Thr 
465                 470                 475                 480 
Arg Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Arg Met 
                485                 490                 495     
Glu Asp Gly Val Trp Trp Glu Ala Arg Ser Leu Thr Thr Gly Glu Thr 
            500                 505                 510         
Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
        515                 520                 525         

<210> 166
<211> 213
<212> PRT
<213> Artificial Sequence

<220> 
<223> COVA422 Light Chain

<400> 166
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      
Asp Arg Val Thr Ile Thr Cys Ser Ala Ser Ser Ser Val Ser Tyr Met 
            20                  25                  30          
Asn Trp Tyr Gln Gln Thr Pro Gly Lys Ala Pro Lys Arg Trp Ile Tyr 
        35                  40                  45              
Asp Thr Ser Lys Leu Ala Ser Gly Val Pro Ser Arg Phe Ser Gly Ser 
    50                  55                  60                  
Gly Ser Gly Thr Asp Tyr Thr Phe Thr Ile Ser Ser Leu Gln Pro Glu 
65                  70                  75                  80  
Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Trp Ser Ser Asn Pro Phe Thr 
                85                  90                  95      
Phe Gly Gln Gly Thr Lys Leu Gln Ile Thr Arg Thr Val Ala Ala Pro 
            100                 105                 110         
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr 
        115                 120                 125             
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys 
    130                 135                 140                 
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu 
145                 150                 155                 160 
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser 
                165                 170                 175     
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala 
            180                 185                 190         
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe 
        195                 200                 205             
Asn Arg Gly Glu Cys 
    210             

<210> 167
<211> 495
<212> PRT
<213> Artificial Sequence

<220> 
<223> COVA446: anti-HER2 x anti CD3 single chain Fv

<400> 167
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Asn Ile Lys Asp Thr 
            20                  25                  30          
Tyr Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              
Ala Arg Ile Tyr Pro Thr Asn Gly Tyr Thr Arg Tyr Ala Asp Ser Val 
    50                  55                  60                  
Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser Lys Asn Thr Ala Tyr 
65                  70                  75                  80  
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      
Ser Arg Trp Gly Gly Asp Gly Phe Tyr Ala Met Asp Tyr Trp Gly Gln 
            100                 105                 110         
Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly 
        115                 120                 125             
Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser 
    130                 135                 140                 
Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ala 
145                 150                 155                 160 
Ser Gln Asp Val Asn Thr Ala Val Ala Trp Tyr Gln Gln Lys Pro Gly 
                165                 170                 175     
Lys Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Phe Leu Tyr Ser Gly 
            180                 185                 190         
Val Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly Thr Asp Phe Thr Leu 
        195                 200                 205             
Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln 
    210                 215                 220                 
Gln His Tyr Thr Thr Pro Pro Thr Phe Gly Gln Gly Thr Lys Val Glu 
225                 230                 235                 240 
Ile Lys Gly Gly Gly Gly Ser Glu Val Gln Leu Val Glu Ser Gly Gly 
                245                 250                 255     
Gly Leu Val Gln Pro Gly Gly Ser Leu Lys Leu Ser Cys Ala Ala Ser 
            260                 265                 270         
Gly Phe Thr Phe Asn Lys Tyr Ala Met Trp Val Arg Gln Ala Pro Gly 
        275                 280                 285             
Lys Gly Leu Glu Trp Val Ala Arg Ile Arg Ser Lys Tyr Asn Asn Tyr 
    290                 295                 300                 
Ala Thr Tyr Tyr Ala Asp Ser Val Lys Asp Arg Phe Thr Ile Ser Arg 
305                 310                 315                 320 
Asp Asp Ser Lys Asn Thr Ala Tyr Leu Gln Met Asn Asn Leu Lys Thr 
                325                 330                 335     
Glu Asp Thr Ala Val Tyr Tyr Cys Val Arg His Gly Asn Phe Gly Asn 
            340                 345                 350         
Ser Tyr Ile Ser Tyr Trp Ala Tyr Trp Gly Gln Gly Thr Leu Val Thr 
        355                 360                 365             
Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly 
    370                 375                 380                 
Gly Ser Gln Thr Val Val Thr Gln Glu Pro Ser Leu Thr Val Ser Pro 
385                 390                 395                 400 
Gly Gly Thr Val Thr Leu Thr Cys Gly Ser Ser Thr Gly Ala Val Thr 
                405                 410                 415     
Ser Gly Asn Tyr Pro Asn Trp Val Gln Gln Lys Pro Gly Gln Ala Pro 
            420                 425                 430         
Arg Gly Leu Ile Gly Gly Thr Lys Phe Leu Ala Pro Gly Thr Pro Ala 
        435                 440                 445             
Arg Phe Ser Gly Ser Leu Leu Gly Gly Lys Ala Ala Leu Thr Leu Ser 
    450                 455                 460                 
Gly Val Gln Pro Glu Asp Glu Ala Glu Tyr Tyr Cys Val Leu Trp Tyr 
465                 470                 475                 480 
Ser Asn Arg Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
                485                 490                 495 

<210> 168
<211> 68
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-HER2 Fynomer

<220> 
<221> VARIANT
<222> 12,13,14,15,16,17,18,34,35,36,41,44,53,55,59
<223> Gly, Val, Thr, Leu, Phe, Ala, Tyr, Asp, Ser, His, Lys, Glu, Gln,
      Ile, Trp, Arg, Met, Pro, Asn

<220> 
<221> VARIANT
<222> 19,20,21,37,38,39
<223> Gly, Val, Thr, Leu, Phe, Ala, Tyr, Asp, Ser, His, Lys, Glu, Gln,
      Ile, Trp, Arg, Met, Pro, Asn

<400> 168
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      
Xaa Xaa Xaa Xaa Xaa Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu Xaa Xaa Xaa Xaa Xaa Xaa Gly Xaa Trp Trp Xaa Ala Arg Ser Leu 
        35                  40                  45              
Thr Thr Gly Glu Xaa Gly Xaa Ile Pro Ser Xaa Tyr Val Ala Pro Val 
    50                  55                  60                  
Asp Ser Ile Gln 
65              

<210> 169
<211> 66
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-EGFR Fynomer ER7L2D6

<400> 169
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Gly Leu 
1               5                   10                  15      
Asn Arg Met Phe Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu Ser Phe Glu Thr Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr 
        35                  40                  45              
Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser 
    50                  55                  60                  
Ile Gln 
65      

<210> 170
<211> 532
<212> PRT
<213> Artificial Sequence

<220> 
<223> COVA493 HC

<400> 170
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Gly Leu 
1               5                   10                  15      
Asn Arg Met Phe Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu Ser Phe Glu Thr Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr 
        35                  40                  45              
Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser 
    50                  55                  60                  
Ile Gln Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly 
65                  70                  75                  80  
Ser Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Leu Ala Arg Pro Gly 
                85                  90                  95      
Ala Ser Val Lys Met Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg 
            100                 105                 110         
Ser Thr Met His Trp Val Lys Gln Arg Pro Gly Gln Gly Leu Glu Trp 
        115                 120                 125             
Ile Gly Tyr Ile Asn Pro Ser Ser Ala Tyr Thr Asn Tyr Asn Gln Lys 
    130                 135                 140                 
Phe Lys Asp Lys Ala Thr Leu Thr Ala Asp Lys Ser Ser Ser Thr Ala 
145                 150                 155                 160 
Tyr Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Tyr 
                165                 170                 175     
Cys Ala Ser Pro Gln Val His Tyr Asp Tyr Asn Gly Phe Pro Tyr Trp 
            180                 185                 190         
Gly Gln Gly Thr Leu Val Thr Val Ser Ala Ala Ser Thr Lys Gly Pro 
        195                 200                 205             
Ser Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr 
    210                 215                 220                 
Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr 
225                 230                 235                 240 
Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro 
                245                 250                 255     
Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr 
            260                 265                 270         
Val Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn 
        275                 280                 285             
His Lys Pro Ser Asn Thr Lys Val Asp Lys Lys Val Glu Pro Lys Ser 
    290                 295                 300                 
Cys Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu 
305                 310                 315                 320 
Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu 
                325                 330                 335     
Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Ala Val Ser 
            340                 345                 350         
His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu 
        355                 360                 365             
Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr 
    370                 375                 380                 
Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn 
385                 390                 395                 400 
Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Ala Ala Pro 
                405                 410                 415     
Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln 
            420                 425                 430         
Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val 
        435                 440                 445             
Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val 
    450                 455                 460                 
Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro 
465                 470                 475                 480 
Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr 
                485                 490                 495     
Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val 
            500                 505                 510         
Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu 
        515                 520                 525             
Ser Pro Gly Lys 
    530         

<210> 171
<211> 451
<212> PRT
<213> Artificial Sequence

<220> 
<223> COVA489 HC, anti-CD3 antibody

<400> 171
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Leu Ala Arg Pro Gly Ala 
1               5                   10                  15      
Ser Val Lys Met Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Ser 
            20                  25                  30          
Thr Met His Trp Val Lys Gln Arg Pro Gly Gln Gly Leu Glu Trp Ile 
        35                  40                  45              
Gly Tyr Ile Asn Pro Ser Ser Ala Tyr Thr Asn Tyr Asn Gln Lys Phe 
    50                  55                  60                  
Lys Asp Lys Ala Thr Leu Thr Ala Asp Lys Ser Ser Ser Thr Ala Tyr 
65                  70                  75                  80  
Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Tyr Cys 
                85                  90                  95      
Ala Ser Pro Gln Val His Tyr Asp Tyr Asn Gly Phe Pro Tyr Trp Gly 
            100                 105                 110         
Gln Gly Thr Leu Val Thr Val Ser Ala Ala Ser Thr Lys Gly Pro Ser 
        115                 120                 125             
Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala 
    130                 135                 140                 
Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val 
145                 150                 155                 160 
Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala 
                165                 170                 175     
Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val 
            180                 185                 190         
Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His 
        195                 200                 205             
Lys Pro Ser Asn Thr Lys Val Asp Lys Lys Val Glu Pro Lys Ser Cys 
    210                 215                 220                 
Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly 
225                 230                 235                 240 
Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met 
                245                 250                 255     
Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Ala Val Ser His 
            260                 265                 270         
Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val 
        275                 280                 285             
His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr 
    290                 295                 300                 
Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly 
305                 310                 315                 320 
Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Ala Ala Pro Ile 
                325                 330                 335     
Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val 
            340                 345                 350         
Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser 
        355                 360                 365             
Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu 
    370                 375                 380                 
Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro 
385                 390                 395                 400 
Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val 
                405                 410                 415     
Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met 
            420                 425                 430         
His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser 
        435                 440                 445             
Pro Gly Lys 
    450     

<210> 172
<211> 213
<212> PRT
<213> Artificial Sequence

<220> 
<223> COVA489 LC, anti-CD3 antibody

<400> 172
Gln Val Val Leu Thr Gln Ser Pro Ala Ile Met Ser Ala Phe Pro Gly 
1               5                   10                  15      
Glu Lys Val Thr Met Thr Cys Ser Ala Ser Ser Ser Val Ser Tyr Met 
            20                  25                  30          
Asn Trp Tyr Gln Gln Lys Ser Gly Thr Ser Pro Lys Arg Trp Ile Tyr 
        35                  40                  45              
Asp Ser Ser Lys Leu Ala Ser Gly Val Pro Ala Arg Phe Ser Gly Ser 
    50                  55                  60                  
Gly Ser Gly Thr Ser Tyr Ser Leu Thr Ile Ser Ser Met Glu Thr Glu 
65                  70                  75                  80  
Asp Ala Ala Thr Tyr Tyr Cys Gln Gln Trp Ser Arg Asn Pro Pro Thr 
                85                  90                  95      
Phe Gly Gly Gly Thr Lys Leu Gln Ile Thr Arg Thr Val Ala Ala Pro 
            100                 105                 110         
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr 
        115                 120                 125             
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys 
    130                 135                 140                 
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu 
145                 150                 155                 160 
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser 
                165                 170                 175     
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala 
            180                 185                 190         
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe 
        195                 200                 205             
Asn Arg Gly Glu Cys 
    210             

<210> 173
<211> 501
<212> PRT
<213> Artificial Sequence

<220> 
<223> COVA445, anti-EGFR/CD3 scFv control

<400> 173
Asp Ile Leu Leu Thr Gln Ser Pro Val Ile Leu Ser Val Ser Pro Gly 
1               5                   10                  15      
Glu Arg Val Ser Phe Ser Cys Arg Ala Ser Gln Ser Ile Gly Thr Asn 
            20                  25                  30          
Ile His Trp Tyr Gln Gln Arg Thr Asn Gly Ser Pro Arg Leu Leu Ile 
        35                  40                  45              
Lys Tyr Ala Ser Glu Ser Ile Ser Gly Ile Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  
Ser Gly Ser Gly Thr Asp Phe Thr Leu Ser Ile Asn Ser Val Glu Ser 
65                  70                  75                  80  
Glu Asp Ile Ala Asp Tyr Tyr Cys Gln Gln Asn Asn Asn Trp Pro Thr 
                85                  90                  95      
Thr Phe Gly Ala Gly Thr Lys Leu Glu Leu Lys Gly Gly Gly Gly Ser 
            100                 105                 110         
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Val Gln Leu Lys Gln 
        115                 120                 125             
Ser Gly Pro Gly Leu Val Gln Pro Ser Gln Ser Leu Ser Ile Thr Cys 
    130                 135                 140                 
Thr Val Ser Gly Phe Ser Leu Thr Asn Tyr Gly Val His Trp Val Arg 
145                 150                 155                 160 
Gln Ser Pro Gly Lys Gly Leu Glu Trp Leu Gly Val Ile Trp Ser Gly 
                165                 170                 175     
Gly Asn Thr Asp Tyr Asn Thr Pro Phe Thr Ser Arg Leu Ser Ile Asn 
            180                 185                 190         
Lys Asp Asn Ser Lys Ser Gln Val Phe Phe Lys Met Asn Ser Leu Gln 
        195                 200                 205             
Ser Asn Asp Thr Ala Ile Tyr Tyr Cys Ala Arg Ala Leu Thr Tyr Tyr 
    210                 215                 220                 
Asp Tyr Glu Phe Ala Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser 
225                 230                 235                 240 
Ser Gly Gly Gly Gly Ser Glu Val Gln Leu Val Glu Ser Gly Gly Gly 
                245                 250                 255     
Leu Val Gln Pro Gly Gly Ser Leu Lys Leu Ser Cys Ala Ala Ser Gly 
            260                 265                 270         
Phe Thr Phe Asn Lys Tyr Ala Met Asn Trp Val Arg Gln Ala Pro Gly 
        275                 280                 285             
Lys Gly Leu Glu Trp Val Ala Arg Ile Arg Ser Lys Tyr Asn Asn Tyr 
    290                 295                 300                 
Ala Thr Tyr Tyr Ala Asp Ser Val Lys Asp Arg Phe Thr Ile Ser Arg 
305                 310                 315                 320 
Asp Asp Ser Lys Asn Thr Ala Tyr Leu Gln Met Asn Asn Leu Lys Thr 
                325                 330                 335     
Glu Asp Thr Ala Val Tyr Tyr Cys Val Arg His Gly Asn Phe Gly Asn 
            340                 345                 350         
Ser Tyr Ile Ser Tyr Trp Ala Tyr Trp Gly Gln Gly Thr Leu Val Thr 
        355                 360                 365             
Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly 
    370                 375                 380                 
Gly Ser Gln Thr Val Val Thr Gln Glu Pro Ser Leu Thr Val Ser Pro 
385                 390                 395                 400 
Gly Gly Thr Val Thr Leu Thr Cys Gly Ser Ser Thr Gly Ala Val Thr 
                405                 410                 415     
Ser Gly Asn Tyr Pro Asn Trp Val Gln Gln Lys Pro Gly Gln Ala Pro 
            420                 425                 430         
Arg Gly Leu Ile Gly Gly Thr Lys Phe Leu Ala Pro Gly Thr Pro Ala 
        435                 440                 445             
Arg Phe Ser Gly Ser Leu Leu Gly Gly Lys Ala Ala Leu Thr Leu Ser 
    450                 455                 460                 
Gly Val Gln Pro Glu Asp Glu Ala Glu Tyr Tyr Cys Val Leu Trp Tyr 
465                 470                 475                 480 
Ser Asn Arg Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu His 
                485                 490                 495     
His His His His His 
            500     

<210> 174
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-CD33 Fynomer EE1L1B3

<400> 174
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Leu Gly Ala 
1               5                   10                  15      
His Glu Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Asn Ser 
            20                  25                  30          
Ser Glu Gly Pro Phe Trp Glu Ala His Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Trp Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 175
<211> 291
<212> PRT
<213> Artificial Sequence

<220> 
<223> COVA467 LC

<400> 175
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      
Asp Arg Val Thr Ile Thr Cys Ser Ala Ser Ser Ser Val Ser Tyr Met 
            20                  25                  30          
Asn Trp Tyr Gln Gln Thr Pro Gly Lys Ala Pro Lys Arg Trp Ile Tyr 
        35                  40                  45              
Asp Thr Ser Lys Leu Ala Ser Gly Val Pro Ser Arg Phe Ser Gly Ser 
    50                  55                  60                  
Gly Ser Gly Thr Asp Tyr Thr Phe Thr Ile Ser Ser Leu Gln Pro Glu 
65                  70                  75                  80  
Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Trp Ser Ser Asn Pro Phe Thr 
                85                  90                  95      
Phe Gly Gln Gly Thr Lys Leu Gln Ile Thr Arg Thr Val Ala Ala Pro 
            100                 105                 110         
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr 
        115                 120                 125             
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys 
    130                 135                 140                 
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu 
145                 150                 155                 160 
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser 
                165                 170                 175     
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala 
            180                 185                 190         
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe 
        195                 200                 205             
Asn Arg Gly Glu Cys Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly 
    210                 215                 220                 
Gly Gly Gly Ser Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu 
225                 230                 235                 240 
Ala Leu Gly Ala His Glu Leu Ser Phe His Lys Gly Glu Lys Phe Gln 
                245                 250                 255     
Ile Leu Asn Ser Ser Glu Gly Pro Phe Trp Glu Ala His Ser Leu Thr 
            260                 265                 270         
Thr Gly Glu Thr Gly Trp Ile Pro Ser Asn Tyr Val Ala Pro Val Asp 
        275                 280                 285             
Ser Ile Gln 
    290     

<210> 176
<211> 511
<212> PRT
<213> Artificial Sequence

<220> 
<223> COVA463, anti-CD3/CD33 scFv control

<400> 176
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asn Tyr 
            20                  25                  30          
Gly Met Asn Trp Val Lys Gln Ala Pro Gly Gln Gly Leu Lys Trp Met 
        35                  40                  45              
Gly Trp Ile Asn Thr Tyr Thr Gly Glu Pro Thr Tyr Ala Asp Asp Phe 
    50                  55                  60                  
Lys Gly Arg Val Thr Met Thr Ser Asp Thr Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  
Leu Glu Leu His Asn Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      
Ala Arg Trp Ser Trp Ser Asp Gly Tyr Tyr Val Tyr Phe Asp Tyr Trp 
            100                 105                 110         
Gly Gln Gly Thr Thr Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly 
        115                 120                 125             
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Val Met Thr Gln Ser 
    130                 135                 140                 
Pro Asp Ser Leu Thr Val Ser Leu Gly Glu Arg Thr Thr Ile Asn Cys 
145                 150                 155                 160 
Lys Ser Ser Gln Ser Val Leu Asp Ser Ser Lys Asn Lys Asn Ser Leu 
                165                 170                 175     
Ala Trp Tyr Gln Gln Lys Pro Gly Gln Pro Pro Lys Leu Leu Leu Ser 
            180                 185                 190         
Trp Ala Ser Thr Arg Glu Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser 
        195                 200                 205             
Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Asp Ser Leu Gln Pro Glu 
    210                 215                 220                 
Asp Ser Ala Thr Tyr Tyr Cys Gln Gln Ser Ala His Phe Pro Ile Thr 
225                 230                 235                 240 
Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys Ser Gly Gly Gly Gly Ser 
                245                 250                 255     
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
            260                 265                 270         
Ser Leu Lys Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asn Lys Tyr 
        275                 280                 285             
Ala Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
    290                 295                 300                 
Ala Arg Ile Arg Ser Lys Tyr Asn Asn Tyr Ala Thr Tyr Tyr Ala Asp 
305                 310                 315                 320 
Ser Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asp Ser Lys Asn Thr 
                325                 330                 335     
Ala Tyr Leu Gln Met Asn Asn Leu Lys Thr Glu Asp Thr Ala Val Tyr 
            340                 345                 350         
Tyr Cys Val Arg His Gly Asn Phe Gly Asn Ser Tyr Ile Ser Tyr Trp 
        355                 360                 365             
Ala Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly Gly Gly 
    370                 375                 380                 
Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Thr Val Val 
385                 390                 395                 400 
Thr Gln Glu Pro Ser Leu Thr Val Ser Pro Gly Gly Thr Val Thr Leu 
                405                 410                 415     
Thr Cys Gly Ser Ser Thr Gly Ala Val Thr Ser Gly Asn Tyr Pro Asn 
            420                 425                 430         
Trp Val Gln Gln Lys Pro Gly Gln Ala Pro Arg Gly Leu Ile Gly Gly 
        435                 440                 445             
Thr Lys Phe Leu Ala Pro Gly Thr Pro Ala Arg Phe Ser Gly Ser Leu 
    450                 455                 460                 
Leu Gly Gly Lys Ala Ala Leu Thr Leu Ser Gly Val Gln Pro Glu Asp 
465                 470                 475                 480 
Glu Ala Glu Tyr Tyr Cys Val Leu Trp Tyr Ser Asn Arg Trp Val Phe 
                485                 490                 495     
Gly Gly Gly Thr Lys Leu Thr Val Leu His His His His His His 
            500                 505                 510     

<210> 177
<211> 63
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-CD33 Fynomer EE3L11B4

<400> 177
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Leu Gly Ala 
1               5                   10                  15      
His Glu Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Arg Gly 
            20                  25                  30          
Ser Lys Gly Pro Phe Trp Glu Ala His Ser Leu Thr Thr Gly Glu Thr 
        35                  40                  45              
Gly Trp Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60              

<210> 178
<211> 64
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-CD33 Fynomer EE4L12D5

<400> 178
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Leu Gly Ala 
1               5                   10                  15      
His Glu Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ser Ser 
            20                  25                  30          
Leu Ala Val Gly Pro Phe Trp Glu Ala His Ser Leu Thr Thr Gly Glu 
        35                  40                  45              
Thr Gly Trp Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60                  



<210> 179
<211> 64
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-CD33 Fynomer EE4L12D3

<400> 179
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Leu Gly Ala 
1               5                   10                  15      
His Glu Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Met Met 
            20                  25                  30          
Ser Asp Glu Gly Pro Phe Trp Glu Ala His Ser Leu Thr Thr Gly Glu 
        35                  40                  45              
Thr Gly Trp Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60                  



<210> 180
<211> 64
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-CD33 Fynomer EE4L12G1

<400> 180
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Leu Gly Ala 
1               5                   10                  15      
His Glu Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ser Pro 
            20                  25                  30          
Arg Ser Glu Gly Pro Phe Trp Glu Ala His Ser Leu Thr Thr Gly Glu 
        35                  40                  45              
Thr Gly Trp Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60                  



<210> 181
<211> 64
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-CD33 Fynomer EE6L12C6

<400> 181
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Leu Gly Ala 
1               5                   10                  15      
His Glu Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Ser Ser 
            20                  25                  30          
Leu Leu Gln Gly Pro Phe Trp Glu Ala His Ser Leu Thr Thr Gly Glu 
        35                  40                  45              
Thr Gly Trp Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60                  



<210> 182
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-CD33 Fynomer EE23L59C1

<400> 182
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Leu Gly Ala 
1               5                   10                  15      
His Glu Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Asp Val 
            20                  25                  30          
Thr Leu Ala Gly Gly Pro Phe Trp Glu Ala His Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Trp Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 183
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-CD33 Fynomer EE23L59A6A

<400> 183
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Leu Gly Ala 
1               5                   10                  15      
His Glu Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Tyr Val 
            20                  25                  30          
Ala Leu Glu Gly Gly Pro Phe Trp Glu Ala His Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Trp Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 184
<211> 64
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-CD33 Fynomer EE23L62E1

<400> 184
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Leu Gly Ala 
1               5                   10                  15      
His Glu Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Leu Arg 
            20                  25                  30          
Val Gln Leu Gly Pro Phe Trp Glu Ala His Ser Leu Thr Thr Gly Glu 
        35                  40                  45              
Thr Gly Trp Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile Gln 
    50                  55                  60                  



<210> 185
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-CD33 Fynomer EE23L62D6

<400> 185
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Leu Gly Ala 
1               5                   10                  15      
His Glu Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Asp Val 
            20                  25                  30          
Gly Leu Arg Gly Gly Pro Phe Trp Glu Ala His Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Trp Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 186
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-CD33 Fynomer EE23L62H7

<400> 186
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Leu Gly Ala 
1               5                   10                  15      
His Glu Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Leu Arg 
            20                  25                  30          
Leu Val Leu Leu Gly Pro Phe Trp Glu Ala His Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Trp Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 187
<211> 66
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-EGFR Fynomer ER9L3D7

<400> 187
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Gly Leu 
1               5                   10                  15      
Asn Arg Met Phe Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu Ser Thr Glu Asn Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr 
        35                  40                  45              
Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser 
    50                  55                  60                  
Ile Gln 
65      

<210> 188
<211> 66
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-EGFR Fynomer ER5L1E2

<400> 188
Gly Val Thr Leu Phe Val Ala Val Tyr Asp Tyr Glu Ala Arg Gly Leu 
1               5                   10                  15      
Asn Arg Met Phe Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu Asn Arg Glu Ser Glu Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr 
        35                  40                  45              
Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser 
    50                  55                  60                  
Ile Gln 
65      

<210> 189
<211> 66
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-EGFR Fynomer ER5L1E5

<400> 189
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Gly Leu 
1               5                   10                  15      
Asn Arg Met Phe Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu Gln Phe Glu Thr Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr 
        35                  40                  45              
Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser 
    50                  55                  60                  
Ile Gln 
65      

<210> 190
<211> 66
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-EGFR Fynomer ER5L1H3

<400> 190
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Gly Leu 
1               5                   10                  15      
Asn Arg Met Phe Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu Ala Phe Glu Thr Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr 
        35                  40                  45              
Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser 
    50                  55                  60                  
Ile Gln 
65      

<210> 191
<211> 66
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-EGFR Fynomer ER6L1A9

<400> 191
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Gly Leu 
1               5                   10                  15      
Asn Arg Leu Phe Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu Asp Arg Thr Asn Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr 
        35                  40                  45              
Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser 
    50                  55                  60                  
Ile Gln 
65      

<210> 192
<211> 66
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-EGFR Fynomer ER6L1C10

<400> 192
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Gly Leu 
1               5                   10                  15      
His Arg Met Phe Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu Asn Arg Glu Thr Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr 
        35                  40                  45              
Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser 
    50                  55                  60                  
Ile Gln 
65      

<210> 193
<211> 66
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-EGFR Fynomer ER6L1F9

<400> 193
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Gly Leu 
1               5                   10                  15      
Asn Arg Leu Phe Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu Asp Arg Thr Asn Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr 
        35                  40                  45              
Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser 
    50                  55                  60                  
Ile Gln 
65      

<210> 194
<211> 66
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-EGFR Fynomer ER7L2E8

<400> 194
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Gly Leu 
1               5                   10                  15      
Asn Arg Met Phe Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu Thr Arg Glu Thr Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr 
        35                  40                  45              
Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser 
    50                  55                  60                  
Ile Gln 
65      

<210> 195
<211> 67
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-EGFR Fynomer ER8L3G1

<400> 195
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Gly Leu 
1               5                   10                  15      
Asn Arg Met Phe Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu Asp Thr Ser Glu Ser Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr 
        35                  40                  45              
Thr Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp 
    50                  55                  60                  
Ser Ile Gln 
65          

<210> 196
<211> 66
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-EGFR Fynomer 3D5

<400> 196
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Gly Leu 
1               5                   10                  15      
Asn Arg Met Phe Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu Leu Pro Gln Glu Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr 
        35                  40                  45              
Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser 
    50                  55                  60                  
Ile Gln 
65      

<210> 197
<211> 66
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-EGFR Fynomer 1C6

<400> 197
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Gly Leu 
1               5                   10                  15      
His Arg Met Phe Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu Asp Arg Thr Asn Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr 
        35                  40                  45              
Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser 
    50                  55                  60                  
Ile Gln 
65      

<210> 198
<211> 294
<212> PRT
<213> Artificial Sequence

<220> 
<223> COVA494 LC

<400> 198
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Gly Leu 
1               5                   10                  15      
Asn Arg Met Phe Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu Ser Phe Glu Thr Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr 
        35                  40                  45              
Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser 
    50                  55                  60                  
Ile Gln Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly 
65                  70                  75                  80  
Ser Gln Val Val Leu Thr Gln Ser Pro Ala Ile Met Ser Ala Phe Pro 
                85                  90                  95      
Gly Glu Lys Val Thr Met Thr Cys Ser Ala Ser Ser Ser Val Ser Tyr 
            100                 105                 110         
Met Asn Trp Tyr Gln Gln Lys Ser Gly Thr Ser Pro Lys Arg Trp Ile 
        115                 120                 125             
Tyr Asp Ser Ser Lys Leu Ala Ser Gly Val Pro Ala Arg Phe Ser Gly 
    130                 135                 140                 
Ser Gly Ser Gly Thr Ser Tyr Ser Leu Thr Ile Ser Ser Met Glu Thr 
145                 150                 155                 160 
Glu Asp Ala Ala Thr Tyr Tyr Cys Gln Gln Trp Ser Arg Asn Pro Pro 
                165                 170                 175     
Thr Phe Gly Gly Gly Thr Lys Leu Gln Ile Thr Arg Thr Val Ala Ala 
            180                 185                 190         
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly 
        195                 200                 205             
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala 
    210                 215                 220                 
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln 
225                 230                 235                 240 
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser 
                245                 250                 255     
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr 
            260                 265                 270         
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser 
        275                 280                 285             
Phe Asn Arg Gly Glu Cys 
    290                 

<210> 199
<211> 532
<212> PRT
<213> Artificial Sequence

<220> 
<223> COVA497 HC

<400> 199
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Arg Gly Leu 
1               5                   10                  15      
Asn Arg Met Phe Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu Ser Thr Glu Asn Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr Thr 
        35                  40                  45              
Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser 
    50                  55                  60                  
Ile Gln Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly 
65                  70                  75                  80  
Ser Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Leu Ala Arg Pro Gly 
                85                  90                  95      
Ala Ser Val Lys Met Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg 
            100                 105                 110         
Ser Thr Met His Trp Val Lys Gln Arg Pro Gly Gln Gly Leu Glu Trp 
        115                 120                 125             
Ile Gly Tyr Ile Asn Pro Ser Ser Ala Tyr Thr Asn Tyr Asn Gln Lys 
    130                 135                 140                 
Phe Lys Asp Lys Ala Thr Leu Thr Ala Asp Lys Ser Ser Ser Thr Ala 
145                 150                 155                 160 
Tyr Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Tyr 
                165                 170                 175     
Cys Ala Ser Pro Gln Val His Tyr Asp Tyr Asn Gly Phe Pro Tyr Trp 
            180                 185                 190         
Gly Gln Gly Thr Leu Val Thr Val Ser Ala Ala Ser Thr Lys Gly Pro 
        195                 200                 205             
Ser Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr 
    210                 215                 220                 
Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr 
225                 230                 235                 240 
Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro 
                245                 250                 255     
Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr 
            260                 265                 270         
Val Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn 
        275                 280                 285             
His Lys Pro Ser Asn Thr Lys Val Asp Lys Lys Val Glu Pro Lys Ser 
    290                 295                 300                 
Cys Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu 
305                 310                 315                 320 
Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu 
                325                 330                 335     
Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Ala Val Ser 
            340                 345                 350         
His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu 
        355                 360                 365             
Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr 
    370                 375                 380                 
Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn 
385                 390                 395                 400 
Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Ala Ala Pro 
                405                 410                 415     
Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln 
            420                 425                 430         
Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val 
        435                 440                 445             
Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val 
    450                 455                 460                 
Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro 
465                 470                 475                 480 
Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr 
                485                 490                 495     
Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val 
            500                 505                 510         
Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu 
        515                 520                 525             
Ser Pro Gly Lys 
    530         

<210> 200
<211> 294
<212> PRT
<213> Artificial Sequence

<220> 
<223> COVA499 LC

<400> 200
Gln Val Val Leu Thr Gln Ser Pro Ala Ile Met Ser Ala Phe Pro Gly 
1               5                   10                  15      
Glu Lys Val Thr Met Thr Cys Ser Ala Ser Ser Ser Val Ser Tyr Met 
            20                  25                  30          
Asn Trp Tyr Gln Gln Lys Ser Gly Thr Ser Pro Lys Arg Trp Ile Tyr 
        35                  40                  45              
Asp Ser Ser Lys Leu Ala Ser Gly Val Pro Ala Arg Phe Ser Gly Ser 
    50                  55                  60                  
Gly Ser Gly Thr Ser Tyr Ser Leu Thr Ile Ser Ser Met Glu Thr Glu 
65                  70                  75                  80  
Asp Ala Ala Thr Tyr Tyr Cys Gln Gln Trp Ser Arg Asn Pro Pro Thr 
                85                  90                  95      
Phe Gly Gly Gly Thr Lys Leu Gln Ile Thr Arg Thr Val Ala Ala Pro 
            100                 105                 110         
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr 
        115                 120                 125             
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys 
    130                 135                 140                 
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu 
145                 150                 155                 160 
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser 
                165                 170                 175     
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala 
            180                 185                 190         
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe 
        195                 200                 205             
Asn Arg Gly Glu Cys Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly 
    210                 215                 220                 
Gly Gly Gly Ser Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu 
225                 230                 235                 240 
Ala Arg Gly Leu Asn Arg Met Phe Asp Leu Ser Phe His Lys Gly Glu 
                245                 250                 255     
Lys Phe Gln Ile Leu Ser Thr Glu Asn Gly Asp Trp Trp Glu Ala Arg 
            260                 265                 270         
Ser Leu Thr Thr Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala 
        275                 280                 285             
Pro Val Asp Ser Ile Gln 
    290                 

<210> 201
<211> 67
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-EGFR Fynomer

<220> 
<221> VARIANT
<222> 8,17,19,34,35,36,37
<223> Gly, Val, Thr, Leu, Phe, Ala, Tyr, Asp, Ser, His, Lys, Glu, Gln,
      Ile, Trp, Arg, Met, Pro, Asn, Cys

<220> 
<221> VARIANT
<222> 38
<223> Gly, Val, Thr, Leu, Phe, Ala, Tyr, Asp, Ser, His, Lys, Glu, Gln,
      Ile, Trp, Arg, Met, Pro, Asn, Cys or is absent

<400> 201
Gly Val Thr Leu Phe Val Ala Xaa Tyr Asp Tyr Glu Ala Arg Gly Leu 
1               5                   10                  15      
Xaa Arg Xaa Phe Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu Xaa Xaa Xaa Xaa Xaa Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr 
        35                  40                  45              
Thr Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp 
    50                  55                  60                  
Ser Ile Gln 
65          

<210> 202
<211> 67
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-EGFR Fynomer

<220> 
<221> VARIANT
<222> 8,17,19,34,35,36,37
<223> Gly, Val, Thr, Leu, Phe, Ala, Tyr, Asp, Ser, His, Lys, Glu, Gln,
      Ile, Trp, Arg, Met, Pro, Asn

<220> 
<221> VARIANT
<222> 38
<223> Gly, Val, Thr, Leu, Phe, Ala, Tyr, Asp, Ser, His, Lys, Glu, Gln,
      Ile, Trp, Arg, Met, Pro, Asn or is absent

<400> 202
Gly Val Thr Leu Phe Val Ala Xaa Tyr Asp Tyr Glu Ala Arg Gly Leu 
1               5                   10                  15      
Xaa Arg Xaa Phe Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu Xaa Xaa Xaa Xaa Xaa Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr 
        35                  40                  45              
Thr Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp 
    50                  55                  60                  
Ser Ile Gln 
65          

<210> 203
<211> 67
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-EGFR Fynomer

<220> 
<221> VARIANT
<222> 8
<223> Leu, Val

<220> 
<221> VARIANT
<222> 17
<223> Asn, His

<220> 
<221> VARIANT
<222> 19
<223> Met, Leu

<220> 
<221> VARIANT
<222> 34
<223> Ser, Asn, Gln, Ala, Asp, Thr, Leu

<220> 
<221> VARIANT
<222> 35
<223> Phe, Thr, Arg, Pro

<220> 
<221> VARIANT
<222> 36
<223> Ser, Glu, Thr, Gln

<220> 
<221> VARIANT
<222> 37
<223> Glu, Thr, Ser, Asn

<220> 
<221> VARIANT
<222> 38
<223> Ser or is absent

<400> 203
Gly Val Thr Leu Phe Val Ala Xaa Tyr Asp Tyr Glu Ala Arg Gly Leu 
1               5                   10                  15      
Xaa Arg Xaa Phe Asp Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile 
            20                  25                  30          
Leu Xaa Xaa Xaa Xaa Xaa Gly Asp Trp Trp Glu Ala Arg Ser Leu Thr 
        35                  40                  45              
Thr Gly Glu Thr Gly Tyr Ile Pro Ser Asn Tyr Val Ala Pro Val Asp 
    50                  55                  60                  
Ser Ile Gln 
65          

<210> 204
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-EGFR Fynomer RT-loop

<220> 
<221> VARIANT
<222> 6
<223> Asn, His

<220> 
<221> VARIANT
<222> 8
<223> Met, Leu

<400> 204
Glu Ala Arg Gly Leu Xaa Arg Xaa Phe 
1               5                   

<210> 205
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-CD33 Fynomer

<220> 
<221> VARIANT
<222> 31,32,33,34
<223> Gly, Val, Thr, Leu, Phe, Ala, Tyr, Asp, Ser, His, Lys, Glu, Gln,
      Ile, Trp, Arg, Met, Pro, Asn, Cys

<220> 
<221> VARIANT
<222> 35,36
<223> Gly, Val, Thr, Leu, Phe, Ala, Tyr, Asp, Ser, His, Lys, Glu, Gln,
      Ile, Trp, Arg, Met, Pro, Asn, Cys or is absent

<400> 205
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Leu Gly Ala 
1               5                   10                  15      
His Glu Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Xaa Xaa 
            20                  25                  30          
Xaa Xaa Xaa Xaa Gly Pro Phe Trp Glu Ala His Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Trp Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 206
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-CD33 Fynomer

<220> 
<221> VARIANT
<222> 31,32,33,34
<223> Gly, Val, Thr, Leu, Phe, Ala, Tyr, Asp, Ser, His, Lys, Glu, Gln,
      Ile, Trp, Arg, Met, Pro, Asn

<220> 
<221> VARIANT
<222> 35,36
<223> Gly, Val, Thr, Leu, Phe, Ala, Tyr, Asp, Ser, His, Lys, Glu, Gln,
      Ile, Trp, Arg, Met, Pro, Asn or is absent

<400> 206
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Leu Gly Ala 
1               5                   10                  15      
His Glu Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Xaa Xaa 
            20                  25                  30          
Xaa Xaa Xaa Xaa Gly Pro Phe Trp Glu Ala His Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Trp Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 207
<211> 65
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-CD33 Fynomer

<220> 
<221> VARIANT
<222> 31
<223> Asn, Arg, Ser, Leu, Met, Asp, Tyr

<220> 
<221> VARIANT
<222> 32
<223> Ser, Gly, Pro, Arg, Met, Val

<220> 
<221> VARIANT
<222> 33
<223> Leu, Thr, Gly, Ser, Val, Arg, Ala

<220> 
<221> VARIANT
<222> 34
<223> Ser, Ala, Leu, Gln, Asp, Val, Lys, Glu

<220> 
<221> VARIANT
<222> 35
<223> Glu, Val, Gln, Leu, Ala, Arg or is absent

<220> 
<221> VARIANT
<222> 36
<223> Leu, Gly or is absent

<400> 207
Gly Val Thr Leu Phe Val Ala Leu Tyr Asp Tyr Glu Ala Leu Gly Ala 
1               5                   10                  15      
His Glu Leu Ser Phe His Lys Gly Glu Lys Phe Gln Ile Leu Xaa Xaa 
            20                  25                  30          
Xaa Xaa Xaa Xaa Gly Pro Phe Trp Glu Ala His Ser Leu Thr Thr Gly 
        35                  40                  45              
Glu Thr Gly Trp Ile Pro Ser Asn Tyr Val Ala Pro Val Asp Ser Ile 
    50                  55                  60                  
Gln 
65  

<210> 208
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-CD33 Fynomer RT-loop

<400> 208
Glu Ala Leu Gly Ala His Glu 
1               5           

<210> 209
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> anti-EGFR Fynomer RT-loop

<220> 
<221> VARIANT
<222> 6
<223> Ala, Cys, Asp, Glu, Phe, Gly, His, Ile, Lys, Leu, Met, Asn, Pro,
      Gln, Arg, Ser, Thr, Val, Trp, Tyr

<220> 
<221> VARIANT
<222> 8
<223> Ala, Cys, Asp, Glu, Phe, Gly, His, Ile, Lys, Leu, Met, Asn, Pro,
      Gln, Arg, Ser, Thr, Val, Trp, Tyr

<400> 209
Glu Ala Arg Gly Leu Xaa Arg Xaa Phe 
1               5                   

